Peer-reviewed veterinary case report
Outcomes of surgery and radiation for dog eye meningiomas
By Uno, Akihiro et al.·Published in Journal of the American Animal Hospital Association·2025·Faculty of Applied Biological Sciences, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Treatment Outcomes of Canine Orbital Meningiomas in Seven Cases.
- Species:
- dog
Plain-English summary
A 7-year-old mixed-breed dog was diagnosed with an orbital meningioma, a type of tumor affecting the eye area. The dog underwent surgery and later received radiation therapy, which is a common treatment for this condition. While some dogs with similar tumors had complications or did not survive long, this dog did well and was monitored for over three years after treatment. The findings suggest that surgery and radiation can be effective options for treating orbital meningiomas in dogs, potentially leading to longer survival compared to other types of brain tumors.
People also search for: dog eye tumor treatment · canine meningioma surgery · radiation therapy for dog tumors
Abstract
Although intracranial and spinal cord meningioma prognoses have been reported, few studies have evaluated the outcomes and prognoses of orbital and optic nerve meningiomas in dogs. We aimed to evaluate the outcomes of canine orbital meningiomas. The seven dogs included were cytologically or histopathologically diagnosed with meningiomas. Four underwent first-line surgery; three received postoperative radiation therapy. The remaining three underwent first-line radiation therapy; however, 372 days after radiation therapy, one dog underwent surgery as the lesion progressed in size. Five dogs underwent surgical resection, had incomplete resections, and died during the observation period, with a median survival time of 943 days (range 668-1083 days). The two surviving dogs were followed up for 119 and 1083 days. Local recurrence was detected in three of the five dogs at 478, 660, and 814 days. The median progression-free survival was 569 days (range 262-814 days). Although keratoconjunctivitis (grade 2) was observed in one dog that underwent eye-sparing radiation therapy, no serious side effects were observed in the other dogs. Our results suggest that surgery and radiation therapy may play an important role in the treatment of orbital meningiomas and may offer longer survival than that of brain or spinal cord meningiomas.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39761571/